{"id":44117,"date":"2022-05-19T14:01:41","date_gmt":"2022-05-19T12:01:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/"},"modified":"2022-05-19T14:01:41","modified_gmt":"2022-05-19T12:01:41","slug":"paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/","title":{"rendered":"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair"},"content":{"rendered":"<div>\n<p>ENGLEWOOD, Colo.&#8211;(BUSINESS WIRE)&#8211;Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac\u2122 2.0 Soft Tissue Fixation System. The TenoTac\u2122 2.0 Soft Tissue Fixation System uses a titanium threaded implant and was designed to allow for greater capture of soft tissue, streamlined tensioning, and improved fit to the bony surface.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/5\/Paragon_28.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg\"><\/a><\/p>\n<p>\nParagon 28\u2019s CEO, Albert DaCosta, commented, \u201cWith the launch of TenoTac\u2122 2.0, we further refined our initial offering to allow surgeons greater control and precision to address the unique needs of each patient. TenoTac\u2122 2.0 adds to our growing portfolio of soft tissue products and the Hammertoe segment, with opportunities for significant improvements in patient outcomes.\u201d\n<\/p>\n<p>\nThe addition of the TenoTac\u2122 2.0 Soft Tissue Fixation System bolsters Paragon 28\u2019s hammertoe product offering, which includes the Paratrooper\u2122 Plantar Plate System, HammerTube\u2122 Hammertoe System, Mini-Monster\u00ae Screw System, and JAWS Staple System. With this comprehensive portfolio, Paragon 28\u00ae provides its customers innovative forefoot solutions to address flexible and rigid contractures of the lesser toes.\n<\/p>\n<p>\n<b>About Paragon 28, Inc.<\/b>\n<\/p>\n<p>\nBased in Englewood, CO., Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28\u00ae has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, hallux valgus (bunions), hammertoe, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Contact:<\/b><br \/>Gilmartin Group<br \/>\n<br \/>Matt Bacso, CFA<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#x6c;&#x74;&#x6f;&#x3a;m&#97;&#116;&#116;&#x2e;&#x62;&#x61;cs&#111;&#64;&#x67;&#x69;&#x6c;ma&#114;&#116;&#x69;&#x6e;&#x69;r&#46;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x6d;&#x61;&#x74;&#x74;&#x2e;&#98;&#97;&#99;&#115;o&#64;g&#x69;&#x6c;&#x6d;&#x61;&#x72;&#x74;&#105;&#110;&#105;r&#46;c&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>ENGLEWOOD, Colo.&#8211;(BUSINESS WIRE)&#8211;Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac\u2122 2.0 Soft Tissue Fixation System. The TenoTac\u2122 2.0 Soft Tissue Fixation System uses a titanium threaded implant and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44117","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"ENGLEWOOD, Colo.&#8211;(BUSINESS WIRE)&#8211;Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac\u2122 2.0 Soft Tissue Fixation System. The TenoTac\u2122 2.0 Soft Tissue Fixation System uses a titanium threaded implant and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-19T12:01:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair\",\"datePublished\":\"2022-05-19T12:01:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/\"},\"wordCount\":310,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005141\\\/en\\\/1460483\\\/21\\\/Paragon_28.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/\",\"name\":\"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005141\\\/en\\\/1460483\\\/21\\\/Paragon_28.jpg\",\"datePublished\":\"2022-05-19T12:01:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005141\\\/en\\\/1460483\\\/21\\\/Paragon_28.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005141\\\/en\\\/1460483\\\/21\\\/Paragon_28.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/","og_locale":"en_US","og_type":"article","og_title":"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair - Pharma Trend","og_description":"ENGLEWOOD, Colo.&#8211;(BUSINESS WIRE)&#8211;Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced further expansion of its hammertoe and soft-tissue portfolio with the launch of its TenoTac\u2122 2.0 Soft Tissue Fixation System. The TenoTac\u2122 2.0 Soft Tissue Fixation System uses a titanium threaded implant and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-19T12:01:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair","datePublished":"2022-05-19T12:01:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/"},"wordCount":310,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/","url":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/","name":"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg","datePublished":"2022-05-19T12:01:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220519005141\/en\/1460483\/21\/Paragon_28.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/paragon-28-launches-tenotac-2-0-soft-tissue-stabilization-system-for-hammertoe-and-soft-tissue-repair\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Paragon 28 Launches TenoTac\u2122 2.0 Soft Tissue Stabilization System for Hammertoe and Soft Tissue Repair"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44117"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44117\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}